Temporomandibular joint disorder
Drug research and approvals for temporomandibular joint disorder: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 21, 2026, 77 studies of temporomandibular joint disorder are recruiting on ClinicalTrials.gov, and Health Canada has authorized 0 drug trials for it since 2013.
- Recruiting worldwide: 77
- Trials authorized in Canada: 0
- FDA orphan approvals: 0
- EU medicines: 0
- Clinical and Electromyographic Assessment of Occlusal Splint TherapyNCT07878247 · Not applicable · Future University in Egypt · starts Dec 1, 2025
- Masticatory Muscle Activity Using a 24-Hour Wearable DeviceNCT07861906 · Not reported · Midwestern University · starts Jun 1, 2025
- Calcium Gluconate Activated in Anterior Disc Displacement With Reduction of the Temporomandibular JointNCT07855887 · Not applicable · Cairo University · starts Jul 25, 2026
- Effects of Orofacial Myofunctional Therapy and Cervical Stabilization Exercises in Patients With Axis-i Group Iia…NCT07853144 · Not applicable · University of Lahore · starts Oct 15, 2026
- Spinal Mobility, Rigidity, and Kinesiophobia in PD and TMDNCT07850674 · Not reported · Mustafa Kemal University · starts Sep 23, 2026
- Clinical Evaluation of Botulinum Toxin a in the Management of Temporomandibular Myofascial PainNCT07847541 · Phase 2 · Riphah International University · starts Aug 15, 2026
- Evaluation of the Effects of Orthognathic Surgeries on the Temporomandibular Joint Using a Mandibular Movement Analyzer…NCT07828041 · Not reported · Semmelweis University · starts Sep 18, 2024
- Machine Learning for Evaluating and Diagnosing Temporomandibular DisordersNCT07771296 · Not applicable · En Chu Kong Hospital · starts Oct 9, 2026
- Twin-Block and LIPUS for TMJ Outcomes in Skeletal Class II PatientsNCT07676695 · Not applicable · Al-Azhar University · starts Jun 18, 2026
How its trials ended
460 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrongOf the 47 whose ending is known, 53% met their primary endpoint, 9% missed it and 38% stopped early.
- Completed, result not reported22549%
- Ongoing11425%
- Status unknown7416%
- Met its primary endpoint255%
- Stopped: other or unclear102%
- Stopped: enrollment or feasibility51%
- Missed its primary endpoint41%
- Stopped: funding2<1%
- Stopped: lack of efficacy1<1%
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA